Mr. Adam El Daba, “Gennecs” CEO, demonstrated his pride and joy to finalize the agreement with the top global vaccines manufacturer “Moderna”.
This agreement is an important milestone, not only for “Gennecs”, but also for the whole Egyptian market introducing such a great product and technology to the Egyptian market, reflecting “Gennecs” ongoing commitment for vaccines supply in Africa.
U.S. Moderna contracts with Gennecs to be its legal representative in Egypt
In “Gennecs” we are committed to bridging the gap across MEA between local demand and global supply for vaccines. As a regional vaccines leader, we are doing our best to secure anti-Covid vaccines during the pandemic.
“Gennecs” by being “Moderna’s” exclusive local representative will pave the way, securing supply of one of the top, globally-rated anti-Covid vaccines to the Egyptian market.
“Gennecs” general manager Dr. Nibal Dahaba expresses her happiness and appreciation for this step highlighting “Gennecs” ongoing commitment to increase the access to vaccination.